XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis - SEC Filings

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.52 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find XTLB SEC filings?

Rallies organizes XTLB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

XTLB Key Metrics

Key financial metrics for XTLB
MetricValue
Price$2.52
Market Cap$6.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$10.28
52-Week Low$2.12
Volume6
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XTLB News

Recent XTLB Insider Trades

  • EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
  • EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
  • EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.

XTLB Analyst Consensus

XTLB analyst coverage data. Average price target: $0.00.

Common questions about XTLB

Where can I find XTLB SEC filings?
Rallies organizes XTLB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show XTLB 10-K and 10-Q filings?
Rallies organizes XTLB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is XTLB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.
XTLB

XTLB